{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-032224","form_type":"8-K","ticker":"EMMA","cik":"0000822370","company_name":"Emmaus Life Sciences, Inc.","filed_at":"2022-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:03.840291+00:00","generated_at":"2026-06-25T02:58:42.197849+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Three Emmaus directors resign after dispute with CEO over financial oversight and cost cuts","bullets":["Lori Teranishi, Alfred Lui, and Jane Pine Wood resigned June 8, 2022, at CEO Yutaka Niihara's request.","Directors stated resignations followed their repeated requests for financial information and business plans.","CEO takes voluntary 30% salary reduction for three months; other senior management take 10% cuts.","Non-essential spending cut, including suspension of EJ Holdings facility retrofitting in Ube, Japan.","Company expects positive operating income later this year via increased Endari sales in U.S. and UAE/GCC."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-032224","json":"https://secwatch.observer/filing/0001213900-22-032224.json","markdown":"https://secwatch.observer/filing/0001213900-22-032224.md","text":"https://secwatch.observer/filing/0001213900-22-032224.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/822370/000121390022032224/0001213900-22-032224-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/822370/000121390022032224/ea161387-8k_emmauslife.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T02:58:42.197849+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"579b03df49","claim":"Lori Teranishi resigned as Director at Emmaus Life Sciences, Inc..","evidence_excerpt":"By letter dated June 8, 2022, Lori Teranishi, Alfred Lui, M.D., and Jane Pine Wood graciously tendered their resignation as directors of Emmaus Life Sciences, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/822370/000121390022032224/0001213900-22-032224-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"68db588254","claim":"Alfred Lui resigned as Director at Emmaus Life Sciences, Inc..","evidence_excerpt":"By letter dated June 8, 2022, Lori Teranishi, Alfred Lui, M.D., and Jane Pine Wood graciously tendered their resignation as directors of Emmaus Life Sciences, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/822370/000121390022032224/0001213900-22-032224-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b7ceb931e1","claim":"Jane Pine Wood resigned as Director at Emmaus Life Sciences, Inc..","evidence_excerpt":"By letter dated June 8, 2022, Lori Teranishi, Alfred Lui, M.D., and Jane Pine Wood graciously tendered their resignation as directors of Emmaus Life Sciences, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/822370/000121390022032224/0001213900-22-032224-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}